Heart valve replacement is an effective therapy for patients with moderate to severe valvular
stenosis or regurgitation. Most bioprosthetic heart valves applied clinically are based on …

With the development of diagnostic techniques, the incidence of bioprosthetic heart valve
thrombosis (BHVT) is found to be seriously underestimated. Developing bioprosthetic heart …

Bioprosthetic heart valves (BHVs), mostly fabricated from glutaraldehyde crosslinked
porcine or bovine pericardium, have been increasingly used in clinic with the application of …

Commercial glutaraldehyde (Glut) cross-linked bioprosthetic heart valves (BHVs) fabricated
from the pericardium have become the most popular choice for treating heart valve …

Bioprosthetic heart valves (BHVs) are widely used in clinic, but they still have problems of
calcification, thrombogenicity, and cytotoxicity. The reported techniques based on …

Bioprosthetic heart valves (BHVs) have been widely used due to the revolutionary
transcatheter aortic valve replacement (TAVR) techniques but suffer from a limited lifespan …

Valvular heart diseases (VHD) have a high incidence in the elderly, and the morbidity and
fatality rate of VHD increase gradually. To save the lives of patients at the end stage of VHD …

Bioprosthetic heart valves (BHVs) have been used widely due to the development of
transcatheter heart valve replacement technology. However, glutaraldehyde crosslinked …

Bioprosthetic heart valves (BHVs) used in clinics are fabricated via glutaraldehyde (GLUT)
crosslinking, which results in cytotoxicity and causes eventual valve calcification after …

Glutaraldehyde crosslinked biological heart valves (BHVs) are increasingly implanted with
development of transcatheter heart valve implantation. While poor cytocompatibility and …